Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_de2076d9a31cb72c082bf1aec6a0ce30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_006e91eddabe95ad7aa889123d31cb9a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-559 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48384 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48607 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-4863 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-48715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-559 |
filingDate |
2014-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bb62f497d9144a85baa36d9b4980735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1a4025ae78c15fa52313d00e54ce0fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c645e8dd3388262e1482e54d5e12e46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e45ff17d687df2c6d1d2f722a2a4e858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd8ec0534ac4ed1e32a147b5090df99e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adaaebf5a1cd2a40ca76f72e8f4b61c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_188a4e8e6ecb8bcc7be8db742acb6fe2 |
publicationDate |
2016-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9375488-B2 |
titleOfInvention |
Compounds to fibroblast growth factor receptor-3 (FGFR3) and methods of treatment |
abstract |
The invention provides conjugates that consist of a drug moiety agent and a cell binding agent that target human fibroblast growth factor receptor 3 (FGFR3). These conjugates have therapeutic use as they are designed and tailored to target a specific cell population and deliver a powerful cytotoxin inside the cell. The conjugate of the present invention has significant advantages over other conjugates known in the art by providing a targeted tumor therapy as well as bystander activity to neighboring cells in an important oncology receptor that is only moderately expressed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11505611-B2 |
priorityDate |
2013-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |